Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies

References

• Austin, P. C. 2011. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behavioral Research 46 (3):399–424. doi:10.1080/00273171.2011.568786.
   PubMed Web of Science ®Google Scholar
• Bonangelino, P., T. Irony, S. Liang, X. Li, V. Mukhi, S. Ruan, Y. Xu, X. Yang, and C. Wang. 2011. Bayesian approaches in medical device clinical trials: A discussion with examples in the regulatory setting. Journal of Biopharmaceutical Statistics 21 (5):938–953. doi:10.1080/10543406.2011.589650.
   PubMed Web of Science ®Google Scholar
• Buuren, S., and K. Groothuis-Oudshoorn. 2011. Mice: Multivariate imputation by chained equations in rR. Journal of Statistical Groothuis-Oudshoorn 1–6845 (3): 1–67. 45 doi:10.18637/jss.v045.i03
   Google Scholar
• Chen, M.-H., and J. G. Ibrahim. 2000. Power prior distributions for regression models. Statistical Science 15 (1):46–60. doi:10.1214/ss/1009212673.
   Web of Science ®Google Scholar
• Cochran, W. G. 1968. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 295–313. doi:10.2307/2528036.
   PubMed Web of Science ®Google Scholar
• D’Agostino, R. B., Jr, and D. B. Rubin. 2000. Estimating and using propensity scores with partially missing data. Journal of the American Statistical Association 95 (451):749–759. doi:10.1080/01621459.2000.10474263.
   Web of Science ®Google Scholar
• Diamond, A., and J. S. Sekhon. 2013. Genetic matching for estimating causal effects: A general multivariate matching method for achieving balance in observational studies. Review of Economics and Statistics 95 (3):932–945. doi:10.1162/REST_a_00318.
   Web of Science ®Google Scholar
• Duan, Y., K. Ye, and E. P. Smith. 2005. Evaluating water quality using power priors to incorporate historical information. Environmetrics 17 (1):95–106. doi:10.1002/env.752.
   Web of Science ®Google Scholar
• Gamalo, M. A., R. C. Tiwari, and L. M. LaVange. 2014. Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products. Pharmaceutical Statistics 13 (1):25–40. doi:10.1002/pst.1588.
   PubMed Web of Science ®Google Scholar
• Gelman, A. 2006. Prior distributions for variance parameters in hierarchical models (comment on article by browne and draper). Bayesian Analysis 1(3):515–534. doi:10.1214/06-BA117A.
   Web of Science ®Google Scholar
• Hobbs, B. P., B. P. Carlin, S. J. Mandrekar, and D. J. Sargent. 2011. Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials. Biometrics 67 (3):1047–1056. doi:10.1111/biom.2011.67.issue-3.
   PubMed Web of Science ®Google Scholar
• Imai, K., and M. Ratkovic. 2014. Covariate balancing propensity score. Journal of the Royal Statistical Society: Series B (statistical Methodology) 76 (1):243–263. doi:10.1111/rssb.12027.
   Web of Science ®Google Scholar
• Inman, H. F., and E. L. Bradley Jr. 1989. The overlapping coefficient as a measure of agreement between probability distributions and point estimation of the overlap of two normal densities. Communications in Statistics-Theory and Methods 18 (10):3851–3874. doi:10.1080/03610928908830127.
   Web of Science ®Google Scholar
• Lee, B. K., J. Lessler, and E. A. Stuart. 2010. Improving propensity score weighting using machine learning. Statistics in Medicine 29 (3):337–346.
   PubMed Web of Science ®Google Scholar
• Li, F., K. L. Morgan, and A. M. Zaslavsky. 2018. Balancing covariates via Balancing covariates via propensity score weighting. Journal of the American Statistical Association 1–11113 (521): 390–400. 113 1-400 doi:10.1080/01621459.2016.1260466
   Google Scholar
• Li, H., V. Mukhi, N. Lu, Y.-L. Xu, and L. Q. Yue. 2016. A note on good practice of objective propensity score design for premarket nonrandomized medical device studies with an example. Statistics in Biopharmaceutical Research 8 (3):282–286. doi:10.1080/19466315.2016.1148071.
   Web of Science ®Google Scholar
• Lin, J., M. Gamalo-Siebers, and R. Tiwari. 2016. Non-inferiority and networks: Inferring efficacy from a web of data. Pharmaceutical Statistics 15 (1):54–67. doi:10.1002/pst.v15.1.
   PubMed Web of Science ®Google Scholar
• Lunceford, J. K., and M. Davidian. 2004. Stratification and weighting via the propensity score in estimation of causal treatment effects: A comparative study. Statistics in Medicine 23 (19):2937–2960. doi:10.1002/sim.v23:19.
   PubMed Web of Science ®Google Scholar
• Murray, T. A., B. P. Hobbs, T. C. Lystig, and B. P. Carlin. 2014. Semiparametric bayesian commensurate survival model for post-market medical device surveillance with non- exchangeable historical data. Biometrics 70 (1):185–191. doi:10.1111/biom.v70.1.
   PubMed Web of Science ®Google Scholar
• National Research Council. 2010. The prevention and treatment of missing data in clinical trials. Washington, DC: The National Academies Press. doi:10.17226/12955.
   Google Scholar
• Neelon, B., and A. J. O’Malley. 2010. Bayesian analysis using power priors with application to pediatric quality of care. Journal of Biometrics and Biostatistics 1 (1):1–9. doi:10.4172/2155-6180.1000103.
   Google Scholar
• Rosenbaum, P. R., and D. B. Rubin. 1983. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1):41–55. doi:10.1093/biomet/70.1.41.
   Web of Science ®Google Scholar
• Rosenbaum, P. R., and D. B. Rubin. 1984. Reducing bias in observational studies using subclassification on the propensity score. Journal of the American Statistical Association 79 (387):516–524. doi:10.1080/01621459.1984.10478078.
   Web of Science ®Google Scholar
• Rubin, D. B. 1997. Estimating causal effects from large data sets using propensity scores. Annals of Internal Medicine 127 (8_Part_2):757–763. doi:10.7326/0003-4819-127-3-199708010-00022.
   PubMed Web of Science ®Google Scholar
• Rubin, D. B. 2001. Using propensity scores to help design observational studies: Application to the tobacco litigation. Health Services and Outcomes Research Methodology 2 (3–4):169–188. doi:10.1023/A:1020363010465.
   Google Scholar
• Rubin, D. B. 2007. The design versus the analysis of observational studies for causal effects: Parallels with the design of randomized trials. Statistics in Medicine 26 (1):20–36. doi:10.1002/(ISSN)1097-0258.
   PubMed Web of Science ®Google Scholar
• Rubin, D. B. 2008. For objective causal inference, design trumps analysis. The Annals of Applied Statistics 808–840. doi:10.1214/08-AOAS187.
   Web of Science ®Google Scholar
• Stan Development Team. 2018. Stan modeling language users guide and reference manual, Version 2.18.0. http://mc-stan.org.
   Google Scholar
• Stuart, E. A. 2010. Matching methods for causal inference: A review and a look forward. Statistical Science: a Review Journal of the Institute of Mathematical Statistics 25 (1):1. doi:10.1214/09-STS313.
   PubMed Web of Science ®Google Scholar
• U.S. House of Representatives (2015). 21st century cures act. http://docs.house.gov/meetings/IF/IF00/20150519/103516/BILLS-1146ih.pdf.
   Google Scholar
• Yue, L. Q. 2007. Statistical and regulatory issues with the application of propensity score analysis to nonrandomized medical device clinical studies. Journal of Biopharmaceutical Statistics 17 (1):1–13. doi:10.1080/10543400601044691.
   PubMed Web of Science ®Google Scholar
• Yue, L. Q., G. Campbell, N. Lu, Y. Xu, and B. Zuckerman. 2016. Utilizing national and international registries to enhance pre-market medical device regulatory evaluation. Journal of Biopharmaceutical Statistics 26 (6):1136–1145. doi:10.1080/10543406.2016.1226336.
   PubMed Web of Science ®Google Scholar
• Yue, L. Q., N. Lu, and Y. Xu. 2014. Designing premarket observational comparative studies using existing data as controls: Challenges and opportunities. Journal of Biopharmaceutical Statistics 24 (5):994–1010. doi:10.1080/10543406.2014.926367.
   PubMed Web of Science ®Google Scholar
• Zhang, J., C.-W. Ko, L. Nie, Y. Chen, and R. Tiwari. 2019. Bayesian hierarchical methods for meta-analysis combining randomized-controlled and single-arm studies. Statistical Methods in Medical Ko 28 (5):1293–1310. 0962280218754928. doi:10.1177/0962280218754928
   Google Scholar
• Zhao, Y., J. Zalkikar, R. C. Tiwari, and L. M. LaVange. 2014. A bayesian approach for benefit-risk assessment. Statistics in Biopharmaceutical Research 6 (4):326–337. doi:10.1080/19466315.2014.965845.
   Web of Science ®Google Scholar